Abstract
An ever-expanding list of causes has been reported for immediate skin contact reactions, of which most are proteins (molecular weight 10,000 to several hundred thousand daltons), but also chemical compounds of low molecular weight (less than 1,000 Da). Low molecular weight chemical agents can be indeed responsible for immediate contact skin symptoms in the differently defined categories of contact urticaria. The most important chemicals responsible for nonimmunological and immunological contact urticaria are described in this chapter. For purposes of simplification and comprehension, these have been classified into the major families of products that include fragrances and cosmetic ingredients, biocides and preservatives, and drugs, together with other categories.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Giménez-Arnau A, Maurer M, De la Cuadra J, Maibach HI. Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis-“A never ending story”. Eur J Dermatol. 2010;20:552–62.
Ale SI, Maibach HI. Occupational contact urticaria. In: Kanerva L, Elsner P, Wahlberg JE, Maibach HI, editors. Handbook of occupational dermatology. Berlin: Springer; 2000. p. 200–16.
Lahti A. Non-immunologic contact urticaria. Acta Dermatovener (Stockholm). 1980;60(Suppl. 91):1–49.
Kligman AM. The spectrum of contact urticaria: wheals, erythema and pruritus. Dermatologic Clin. 1990;8:57–60.
Coverly J, Peters L, Whittle E, Basketter DA. Susceptibility to skin stinging, non-immunologic contact urticaria and skin irritation-is there a relationship? Contact Dermatitis. 1998;38:90–5.
Lahti A, Vaananen A, Kokkonen E-L, Hannuksela M. Acetylsalicylic acid inhibits non-immunologic contact urticaria. Contact Dermatitis. 1987;16:133–5.
Johansson J, Lahti A. Topical non-steroidal anti-inflammatory drugs inhibit non-immunological immediate contact reactions. Contact Dermatitis. 1988;19:161–5.
Wakelin SH. Contact urticaria. Clin Exp Dermatol. 2001;26:132–6.
Amaro C, Goossens A. Immunological occupational contact urticaria and contact dermatitis from proteins: a review. Contact Dermatitis. 2008;58:67–75.
Goossens A, Amaro C, Géraut C. Urticaire et dermatite de contact aux protéines en pathologie professionnelle. In:Progrès en Dermato-Allergologie. Paris: John Libbey Eurotext; 2007. p. 57–70.
Castanedo-Tardan MP, Jacob SE, Baumann LS. Contact urticaria to cosmetic and toiletry ingredients. Cosmetic Dermatol. 2008;21:339–46.
Lahti A, Basketter D. Immediate contact reactions. In: Johansen JD, Frosch PJ, Lepoittevin J-P, editors. Contact dermatitis. 5th ed. Berlin: Springer; 2011. p. 137–53.
Gleich GJ, Yunginger JW. The radioallergosorbent test: a method to measure IgE antibodies, IgG blocking antibodies, and the potency of allergy extracts. Bull N Y Acad Med. 1981;57:559–67.
Vigan M. Urticaire de contact aux cosmétiques. In:Progrès en Dermato-Allergologie. Paris: John Libbey Eurotext; 2007. p. 17–34.
Cancian M, Fortina AB, Peserico A. Contact urticaria syndrome from constituents of balsam of Peru and fragrance mix in a patient with chronic urticaria. Contact Dermatitis. 1999;41:3000.
Larsen WG. Perfume dermatitis. a study of 20 patients. Arch Dermatol. 1977;113:623–7.
Frosch PJ, Pirker C, Rastogi SC, Andersen K, Bruze M, Svedman C, Goossens A, White IR, Uter W, Giménez-Arnau E, Lepoittevin J-P, Menné T, Johansen JD. Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix. Contact Dermatitis. 2005;52:207–15.
Safford RJ, Basketter DA, Allenby CF, Goodwin BFJ. Immediate contact reactions to chemicals in the fragrance mix and a study of the quenching action of eugenol. Br J Dermatol. 1990;123:595–606.
Diba VC, Statham BN. Contact urticaria from cinnamal leading to anaphylaxis. Contact Dermatitis. 2003;48:119.
Forsbeck M, Skog E. Immediate reactions to patch tests with balsam of Peru. Contact Dermatitis. 1977;3:201–5.
Hausen BM, Simatupang T, Bruhn G, Evers P, Koenig WA. Identification of new allergens constituents and proof of evidence for coniferyl benzoate in balsam of Peru. Am J Contact Dermat. 1995;6:199–208.
Api AM. Only Peru Balsam extracts or distillates are used in perfumery. Contact Dermatitis. 2006;54:179.
Yamamoto A, Morita A, Tsuji T, et al. Contact urticaria from geraniol. Contact Dermatitis. 2002;46:52.
Hagvall L, Bäcktorp C, Svensson S, Nyman G, Börje A, Karlberg AT. Fragrance compound geraniol forms contact allergens on air exposure. identification and quantification of oxidation products and effect on skin sensitization. Chem Res Toxicol. 2007;20:807–14.
Kanerva L, Estlander T, Jolanki R. Dental nurse’s occupational allergic contact dermatitis from eugenol used as a restorative dental material with polymethylmethacrylate. Contact Dermatitis. 1998;38:339–40.
Praven T, Pushpalatha C, Shrenik J, Sowmya SW. An unexpected positive hypersensitive reaction to eugenol. BMJ Case Rep. 2013. https://doi.org/10.1136/bcr-2013-009464.
Marzulli FN, Maibach HI. Contact allergy: predictive testing of fragrance ingredients in humans by Draize and maximization tests. J Environ Pathol Toxicol. 1980;3:243–5.
Tananka S, Royds C, Buckley D, Basketter DA, Goossens A, Bruze M, Svedman C, Menné T, Johansen JD, White IR, McFadden JP. Contact allergy to isoeugenol and its derivatives: problems with allergen substitution. Contact Dermatitis. 2004;51:288–91.
Vocanson M, Valeyrie M, Rozières A, Hennino A, Floc’h F, Gard A, Nicolas JF. Lack of evidence for allergenic properties of coumarin in a fragrance allergy mouse model. Contact Dermatitis. 2007;57:361–4.
Heurung AR, Raju SI, Warshaw EM. Benzophenones. Dermatitis. 2014;25:3–10.
Emonet S, Pasche-Koo F, Perin-Minisini MJ, Hauser C. Anaphylaxis to oxybenzone, a frequent constituent of sunscreens. J Allergy Clin Immunol. 2001;107:556–7.
Yesudian PD, King CM. Severe contact urticarial and anaphylaxis from benzophenone-3 (2-hydroxy-4-methoxy benzophenone). Contact Dermatitis. 2002;46:55–6.
Maibach HI, Conant M. Contact urticarial to a corticosteroid cream: polysorbate 60. Contact Dermatitis. 1977;3:350–1.
Pérez-Pérez L, García Gavín J, Piñeiro B, Zulaica A. Biologic-induced urticarial due to polysorbate 80: usefulness of prick test. Br J Dermatol. 2011;164:1119–20.
Asarch A, Scheinmann PL. Sorbitan sesquiolate: an emerging contact allergen. Dermatitis. 2008;19:339–41.
Hardy H, Maibach H. Contact urticarial syndrome from sorbitan sesquiolate in a corticosteroid ointment. Contact Dermatitis. 1995;32:114.
EWG’s Skin Deep® Cosmetics Database. http://www.ewg.org/skindeep.
Cosmetic Ingredient Review. http://www.cir-safety.org/ingredient/propylene-glycol.
Funk JO, Maibach HI. Propylene glycol dermatitis: re-evaluation of an old problem. Contact Dermatitis. 1994;31:236–41.
Andersen KE, Storrs FJ. Skin irritation caused by propylene glycols. Hautarzt. 1982;33:12–4.
Warshaw EM, Nelsen DD, Maibach HI, Marks JG, Zug KA, et al. Positive patch test reactions to lanolin: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2006. Dermatitis. 2009;20:79–88.
Lundov MB, Moesby L, Zachariae C, Johansen JD. Contamination versus preservation of cosmetics: a review on legislation, usage, infections, and contact allergy. Contact Dermatitis. 2009;60:70–8.
Fryklöf L-E. A note on the irritant properties of sorbic acid in ointments and creams. J Pharm Pharmacol. 1958;10:719–20.
Rietschel RL. Contact urticaria from synthetic cassia oil and sorbic acid limited to the face. Contact Dermatitis. 1978;4:347–9.
Clemmensen O, Hjort N. Perioral contact urticarial from sorbic acid and benzoic acid in salad dressing. Contact Dermatitis. 1982;8:1–6.
Nair B. Final report on the safety assessment of benzyl alcohol, benzoic acid and sodium benzoate. Int J Toxicol. 2001;20:23–50.
Hannuksela M, Haahtela T. Hypersensitivity reactions to food additives. Allergy. 1987;42:561–75.
Public Health England. Formaldehyde: health effects, incident management and toxicology. 2017. https://www.gov.uk/government/publications/formaldehyde-properties-incident-management-and-toxicology.
Eighth Commission Directive 86/199/EC of 26 March 1986 adapting to technical progress Annexes II, IV and VI to council directive 76/768/EC on the approximation of the laws of the member states relating to cosmetic products. Off J Eur Commun 1986; L149:38–45.
Von Krogh G, Maibach HI. Contact urticaria. In: Adam RM, editor. Occupational skin disease. New York: Grune & Stratton; 1983. p. 58–69.
Torresani C, Periti I, Beski L. Contact urticaria syndrome from formaldehyde with multiple physical urticarias. Contact Dermatitis. 1996;35:174–5.
Braun J, Zana H, Purohit A. Anaphylactic reactions to formaldehyde in root canal sealant after endodontic treatment. four cases of anaphylactic shock and three of generalized urticarial. Allergy. 2003;58:1210–4.
Ogawa M, Nishinakagawa S, Yokosawa F, Yoshida T, Endo Y. Formaldehyde-specific IgE-mediated urticaria due to formaldehyde in a room environment. Jpn J Occup Med Traumatol. 2009;57:125–9.
Kireche M, Giménez-Arnau E, Lepoittevin J-P. Preservatives in cosmetics: reactivity of allergenic formaldehyde releasers toward amino acids through breakdown products other than formaldehyde. Contact Dermatitis. 2010;63:192–202.
Schnuch A, Lessmann H, Geier J, Uter W. Contact allergy to preservatives. analysis of IVDK data 1996-2009. Br J Dermatol. 2011;164:1316–25.
Thyssen JP, Engkilde K, Lundov MD, Carlsen BC, Menné T, Johansen JD. Temporal trends of preservative allergy in Denmark (1985-2008). Contact Dermatitis. 2010;62:272–3.
Gonçalo M, Goossens A. Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis. 2013;68:257–8.
Lundov MD, Opstrup MS, Johansen JD. Methylisothiazolinone contact allergy – a growing epidemic. Contact Dermatitis. 2013;69:271–5.
Thyssen JP, Sederberg-Olsen N, Thomsen JF, Menné T. Contact dermatitis from methylisothiazolinone in a paint factory. Contact Dermatitis. 2006;54:322–4.
García-Gavín J, Vansina S, Kerre S, Naert A, Goossens A. Methylisothiazolinone, an emerging allergen in cosmetics? Contact Dermatitis. 2010;63:96–101.
Lundov MD, Zachariae C, Menné T, Johansen JD. Airborne exposure to preservative methylisothiazolinone causes severe allergic reactions. BMJ. 2012;345:e8221.
Geier J, Lessmann H, Schnuch A, Uter W. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis. 2012;67:334–41.
Debeuckelaere C, Moussallieh FM, Elbayed K, Namer IJ, Berl V, Giménez-Arnau E, Lepoittevin J-P. In situ chemical behaviour of methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) in reconstructed human epidermis: a new approach to the cross-reactivity issue. Contact Dermatitis. 2016;74:159–67.
Gebhardt M, Looks A, Hipler UC. Urticaria caused by type IV sensitization to isothiazolinones. Contact Dermatitis. 1997;36:314.
Guin JD, Goodman J. Contact urticaria from benzyl alcohol presenting as intolerance to saline soaks. Contact Dermatitis. 2001;45:182–3.
Walker SL, Chalmers RJG, Beck MH. Contact urticaria due to p-chloro-m-cresol. Br J Dermatol. 2004;151:927–52.
Birnie AJ, English JS. 2-Phenoxyethanol-induced contact urticaria. Contact Dermatitis. 2006;54:349.
Co-Minh HB, Demoly P, Guillot B, Raison-Peyron N. Anaphylactic shock after oral intake and contact urticaria due to polyethylene glycols. Allergy. 2007;62:92–3.
Ophaswongse S, Maibach HI. Alcohol dermatitis: allergic contact dermatitis and contact urticaria syndrome. Contact Dermatitis. 1994;30:1–6.
Uter W. The European surveillance system of contact allergies (ESSCA): results of patch testing the standard series. J Eur Acad Dermatol Venereol. 2008;22:174–81.
Zug KA, Warshaw EM, Fowler JF, et al. Patch-test results of the North American contact dermatitis group 2005-2006. Dermatitis. 2009;20:149–60.
Barranco Sanz P, Martin Muñoz F, Lopez Serrano C, Martin Esteban M, Ojeda Casas JA. Hypersensitivity to mercuric fluorescein compounds. Allergol Immunopathol. 1989;17:219–22.
Corrales Torres JL, De Corres F. Anaphylactic hypersensitivity to mercurochrome (merbrominum). Ann Allergy. 1985;54:230–2.
Dooms-Goossens A, Gevers D, Mertens A, Vanderheyden D. Allergic contact urticaria due to chloramine. Contact Dermatitis. 1983;9:319–20.
Kramps JA, van Toorenenbergen AW, Vooren PH, Dijkman JH. Occupational asthma due to inhalation of chloramine-T. II Demonstration of specific IgE antibodies. Int Arch Allergy Appl Immunol. 1981;64:428–38.
Kanerva L, Alanko K, Estlander T, Sihvonen T, Jolanki R. Occupational allergic contact urticaria from chloramine-T solution. Contact Dermatitis. 1997;37:180–1.
Sinaiko R, Heinemann C, Maibach HI. Contact urticaria and anaphylaxis to Chlorhexidine. In: Zhai H, Wilhelm KP, Maibach HI, editors. Dermatotoxicology. Boca Raton: CRC Press; 2007. p. 485–95.
Nagendran V, Wicking J, Ekbote A, Onyekwe T, Garvey LH. Ig-E mediated chlorhexidine allergy: a new occupational hazard? Occup Med. 2009;59:270–2.
Calogiuri GF, Di Leo E, Trautmann A, Nettis E, Ferrannini A, Vacca A. Chlorhexidine hypersensitivity: a critical and updated review. J Allergy Ther. 2013;4:141.
Walker S, Chalmers R, Beck M. Contact urticaria due to p-chloro-m-cresol. Br J Dermatol. 2004;151:936–7.
Goncalo M, Goncalo S, Moreno A. Immediate and delayed sensitivity to chlorocresol. Contact Dermatitis. 1987;17:46–7.
Jovanovic M, Karadaglic D, Brkic S. Contact urticaria and allergic contact dermatitis to lidocaine in a patient sensitive to benzocaine and propolis. Contact Dermatitis. 2006;54:124–6.
Waton J, Boulanger A, Trechot PH, Schumtz JL, Barbaud A. Contact urticaria from Emla cream. Contact Dermatitis. 2004;51:284–7.
Suzuki T, Kawada A, Yashimoto Y, Isogai R, Aragane Y, Tezuka T. Contact urticaria to ketoprofen. Contact Dermatitis. 2003;48:284–5.
Arroliga ME, Pien L. Penicillin allergy: consider trying penicillin again. Cleveland Clinic J Med. 2003;70:313–26.
Nola RC, Puy R, Deckert K, O’Hehir RE, Douglass JA. Experience with a new commercial skin testing kit to identify IgE-mediated penicillin allergy. Int Med J. 2008;38:357–67.
Kim MH, Lee JM. Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Allergy Asthma Immunol Res. 2014;6:485–95.
Romano A, Mayorga C, Torres MJ, Artesani MC, Suau R, Sanchez F, Perez E, Venuti A, Blanca M. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol. 2000;106:1177–83.
Kim JE, Kim SH, Jin HJ, Hwang EK, Kim JH, Ye YM, Park HS. IgE sensitization to cephalosporins in health care workers. Allergy Asthma Immunol Res. 2012;4:85–91.
Ariza A, García-Martín E, Salas M, Montañez MI, Mayorga C, et al. Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole. Sci Rep. 2016;6:23845.
Brandão FM, Goossens A. Topical drugs. In: Johansen JD, Frosch PJ, Lepoittevin J-P, editors. Contact dermatitis. 5th ed. Berlin: Springer; 2011. p. 729–62.
Rasanen L, Tarvainen K, Makinen-Kiljunen S. Urticaria to hydrocortisone. Allergy. 2001;56:352–3.
Nettis E, Muratore L, Valogiuri G, Ferrannini A, Tursi A. Urticaria to hydrocortisone. Allergy. 2001;56:802–3.
Helaskoski E, Kuuliala O, Aalto-Korte K. Occupational contact urticaria caused by cyclic acid anhydrides. Contact Dermatitis. 2009;60:214–21.
Kanerva L, Jolanki R, Tupasela O, Halmepuro L, Keskinen H, Estlander T, Sysilampi ML. Immediate and delayed allergy from epoxy resins based on diglycidyl ether of bisphenol a. Scand J Work Environ Health. 1991;17:208–15.
Kanerva L, Pelttari M, Jolanki R, Alanko K, Estlander T, Suhonen R. Occupational contact urticarial from diglycidyl ether of bisphenol A epoxy resin. Allergy. 2002;57:1205–7.
Kanerva L, Tokannen J, Jolanki R, Estlander T. Statistical data on occupational contact urticaria. Contact Dermatitis. 1996;35:229–33.
Koopmans AK, Bruynzeel DP. Is PPD a useful screening agent? Contact Dermatitis. 2003;48:89–92.
Seidenari S, Mantovani L, Manzini BM, Pignatti M. Cross-sensitizations between azo dyes and para-amino compound. Contact Dermatitis. 1997;36:91–6.
Uter W, Geier J, Lessmann H, Hausen BM. Contact allergy to disperse blue 106 and disperse blue 124 in german and austrian patients, 1995 to 1999. Contact Dermatitis. 2001;44:173–7.
Wong GA, King CM. Immediate-type hypersensitivity and allergic contact dermatitis due to para-phenylenediamine in hair dye. Contact Dermatitis. 2003;48:166.
Sosted H, Agner T, Andersen KE, Menné T. 55 cases of allergic reactions to hair dye: a descriptive consumer complaint-based study. Contact Dermatitis. 2002;47:299–303.
Goldberg BJ, Hermnn FF, Hirata I. Systemic anaphylaxis due ton an oxidation product of p-phenylenediamine in a hair dye. Ann Allergy. 1987;58:205–8.
Helgesen AL, Austad J. Contact urticaria from aluminium and nickel in the same patient. Contact Dermatitis. 1997;37:303–4.
Kreciscz B, Kiec-Swierczynska M, Krawczyk P, Chomiczewska D, Palczynski C. Cobalt-induced anaphylaxis, contact urticaria and delayed allergy I a ceramics decorator. Contact Dermatitis. 2009;60:173–4.
Bergman A, Svedberg U, Nilsson E. Contact urticaria with anaphylactic reactions caused by occupational exposure to iridium salt. Contact Dermatitis. 1995;32:14–7.
Estlander T, Kanerva L, Tupasela O, Keskinen H, Jolanki R. Immediate and delayed allergy to nickel with contact urticaria, rhinitis, asthma and contact dermatitis. Clin Exp Allergy. 1993;23:306–10.
Cristaudo A, Sera F, Severino V, De Rocco M, Di Lella E, Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy. 2005;60:159–64.
Schena D, Barba A, Costa G. Occupational contact urticaria due to cisplatin. Contact Dermatitis. 1996;34:220–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Giménez-Arnau, E. (2018). Immediate Skin Contact Reactions Induced by Chemicals. In: Giménez-Arnau, A., Maibach, H. (eds) Contact Urticaria Syndrome. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-89764-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-89764-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89763-9
Online ISBN: 978-3-319-89764-6
eBook Packages: MedicineMedicine (R0)